Evidence map›Paper›PMID 30405832›Full record

ArticleJournal of Cancer2018

Variants in the 3'-untranslated region of CUL3 is associated with risk of esophageal squamous cell carcinoma.

Jin-Long Hu, Xin-Long Hu, Chuang-Xin Lu, Xue-Jiao Chen, Lei Fu, Qian Han, Shun-Dong Cang

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jin-Long HuDepartment of Oncology, People's Hospital of Zhengzhou University and Henan Provincial People's Hospital, Zhengzhou 450000, P. R. China.
Xin-Long HuDepartment of Medical Imaging Technology, Henan University of Chinese Medicine, Zhengzhou 450000, P. R. China.
Chuang-Xin LuDepartment of Oncology, People's Hospital of Zhengzhou University and Henan Provincial People's Hospital, Zhengzhou 450000, P. R. China.
Xue-Jiao ChenDepartment of Oncology, People's Hospital of Zhengzhou University and Henan Provincial People's Hospital, Zhengzhou 450000, P. R. China.
Lei FuDepartment of Oncology, People's Hospital of Zhengzhou University and Henan Provincial People's Hospital, Zhengzhou 450000, P. R. China.
Qian HanDepartment of Radiotherapy, People's Hospital of Zhengzhou University and Henan Provincial People's Hospital, Zhengzhou 450000, P. R. China.
Shun-Dong CangDepartment of Oncology, People's Hospital of Zhengzhou University and Henan Provincial People's Hospital, Zhengzhou 450000, P. R. China.
Zhengzhou University · CNHenan Provincial People's Hospital · CNFirst Affiliated Hospital of Henan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

3'UTRCUL3Esophageal squamous cell carcinomaSNPSusceptibility

Identifiers

PMID30405832
PMCPMC6216002
OpenAlexW2891537688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.